Tower Research Capital LLC (TRC) - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q2 2023$22
+266.7%
5
-99.7%
0.00%
Q1 2023$6
-66.7%
1,721
-66.3%
0.00%
-100.0%
Q4 2022$18
-99.7%
5,103
+50.4%
0.00%
Q3 2022$7,000
+16.7%
3,392
+8.2%
0.00%
Q2 2022$6,0003,136
+313500.0%
0.00%
Q4 2021$0
-100.0%
1
-100.0%
0.00%
Q2 2021$17,000
+13.3%
3,312
+31.0%
0.00%
Q1 2021$15,000
+400.0%
2,528
+465.5%
0.00%
Q4 2020$3,0004470.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders